-
Breakthrough Leukemia Treatment Backfires In A Rare Case
Oct 1, 2018, 15:32 PM by Michael CroftThe New York Times | A highly unusual death has exposed a weak spot in a groundbreaking cancer treatment: One rogue cell, genetically altered by the therapy, can spiral out of control in a patient and cause a fatal relapse.Full story -
Bio-IT World Launches Innovative Practices Awards, Opens Call For Entries
Oct 1, 2018, 07:40 AM by Michael CroftFull storyBio-IT World | In 2019 Bio-IT World is launching the Innovative Practices Awards, an elite awards program designed to recognize partnerships and projects pushing our industry forward.
-
Protein Dynamic Solutions recipient of NSF SBIR Phase IIB Supplemental award
Sep 30, 2018, 18:45 PM by Michael CroftWAKEFIELD, MA - Oct 1, 2018 - Protein Dynamic Solutions (PDS) was awardeda Small Business Innovation Research (SBIR) Phase IIB grant from the National Science Foundation (NSF) to focus on innovative breakthrough applications and commercialization of ProteinMentorTMplatform technology for pre-clinical candidate selection and to help ensure safety and efficacy of therapeutic proteinsFull story -
UgenTec to extend its software portfolio with FastTyper, a platform used for high-throughput SNP genotyping by end-point PCR
Sep 28, 2018, 12:50 PM by Michael CroftBOSTON, MA - Sep 28, 2018 - UgenTec today announced a new end-point PCR analysis software called FastTyper. FastTyper uses artificial intelligence (AI) methods to significantly accelerate genotyping analysis workflows and improve data interpretation in applications such as agricultural breeding programsFull story -
Symbiosis secures FDA viral vector process approval
Sep 27, 2018, 06:11 AM by Michael CroftNEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 27, 2018 - Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UKFull story -
Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs
Sep 27, 2018, 05:40 AM by Michael CroftMOTHERWELL, SCOTLAND - Sep 27, 2018 - Clyde Biosciences, the leader in cardiac cell function assessment, announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro cardiac safety evaluation of new drugsFull story -
Equus, Thermo Fisher Scientific, NVIDIA, And More: News From September 2018
Sep 26, 2018, 12:55 PM by Michael CroftFull storyBio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Equus, Thermo Fisher Scientific, NVIDIA, and more.
-
Thermo Fisher Scientific Expands Genome Editing IP Portfolio
Sep 26, 2018, 11:04 AM by Michael CroftCARLSBAD, CA, UNITED STATES - Sep 18, 2018 - Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolioFull story -
NIH-Funded Genome Centers To Accelerate Precision Medicine Discoveries
Sep 26, 2018, 10:00 AM by Michael CroftFull storyBio-IT World News Brief | The All of Us Research Program awarded funds totaling $28.6 million to establish three genome centers around the country.
-
Qlucore AB announces changes to Board of Directors
Sep 26, 2018, 09:54 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Sep 26, 2018 - Pia Gideon has been appointed Chair, having served on the Board of Qlucore AB since 2009. She was previously the Vice President of Marketing and Communication at EricssonFull story -
Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care
Sep 26, 2018, 08:16 AM by Michael CroftPRINCETON, NJ, US - Sep 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patientsFull story -
LabKey and Linguamatics Partner to Extract Clinical Insights from Big Data in Healthcare
Sep 25, 2018, 11:04 AM by Michael CroftCAMBRIDGE, N/A, UNITED KINGDOM - Sep 25, 2018 - Linguamatics, the leading natural language processing (NLP) text analytics provider, and LabKey, a provider of bioinformatics data management solutions, today announced an integrated solution designed to streamline the extraction and curation of valuable insights from large volumes of unstructured clinical notes and reportsFull story -
Quanticate partners with CluePoints™ to offer Data Quality Oversight
Sep 25, 2018, 04:31 AM by Michael CroftLONDON, UNITED KINGDOM - Sep 25, 2018 - Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelinesFull story -
BioIVT to Host the 2018 HEPATOPAC® User Group Meeting in Boston
Sep 24, 2018, 13:04 PM by Michael CroftWESTBURY, NY, US - Sep 24, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be hosting the 2018 HEPATOPAC User Group Meeting (UGM) from 8:30 aFull story -
A $100 Million Biotech Deal Is Also A Tale Of Two Executives Facing Their Kids Deadly Diseases
Sep 21, 2018, 14:42 PM by Michael CroftForbes | Amicus Therapertics is purchasing a portfolio of ten gene therapies for $100 million. But there's more to this story than most business deals.Full story -
Canines-N-Kids Foundation To Host Symposium, Aims To Accelerate Drug Development For Child, Dog Cancers
Sep 21, 2018, 13:40 PM by Michael CroftFull storyBio-IT World News Brief | Canines-N-Kids Foundation is hosting the Paws for a Cure Research Symposium this November at the Merck Research Laboratories in Boston. The Foundation hopes to examine challenges and progress in accelerating cancer drug development for cancers shared between children and dogs.
-
H1 Launches “Strategy As A Service” Offering, Helps Life Sciences Companies Cut Time-To-Market In Half
Sep 21, 2018, 12:35 PM by Michael CroftFull storyBio-IT World News Brief | H1 launched a new Strategy as a Service offering designed to help clients accelerate the market research phase of drug development.
-
Cray Picks Up Two Supercomputer Wins In Asia
Sep 21, 2018, 07:22 AM by Michael CroftTOP500 | Cray has announced two new XC50 supercomputers that were purchased by research organizations in Japan and South Korea.Full story -
ABclonal Technology Unveils Next-Generation Sequencing Kits For Illumina Sequencing Platforms
Sep 20, 2018, 16:01 PM by Michael CroftBOSTON, MA, UNITED STATES - Sep 13, 2018 - ABclonal Technology, a dynamic and growing provider of biological reagents for life science research, today unveiled its new line of next-generation sequencing library preparation kits (NGS lib prep kits), one of the industrys highest-yielding DNA and RNA library preparation kitsFull story -
H1 Launches ‘Strategy as a Service’ Offering That Helps Life Sciences Companies Cut Time-to-Market in Half
Sep 20, 2018, 13:50 PM by Michael CroftNEW YORK CITY, NY, US - Sep 20, 2018 - FOR IMMEDIATE RELEASE Media contact:Michelle FaulknerFull story
+1 617-510-6998
michelle@big-swing